Alddo Molinar and His Success Story

Dr. Alddo Molinar is a physician and scientist. He is the Director of Clinical Research at the University of Miami Miller School of Medicine. Alddo Molinar has several books and articles published. This, as well as many patents assigned to healthcare companies, universities, and Federal agencies in Europe, Asia, South America, and North America. Alddo Molinar’s scientific career began with conducting clinical trials in Europe while attending medical school. He graduated from the Renal Medicine Section in Italy.


Here, he completed his internship and residency training programs in Nephrology. Molinar’s career as a scientist began in 1987. He served as a scientist at the University of Miami, where he continued his clinical training and research efforts. During his time at the School of Medicine, Alddo Molinar conducted research in physiology and medicine. He focused on multiple organ systems, including cardiovascular, genitourinary, pulmonary, gastrointestinal, endocrine, and reproductive. 


Critical Care Medicine Expert Alddo Molinar


Anesthesiologist Dr. Alddo Molinar has published research in multiple scientific journals and has secured multiple patents. His clinical and scientific work has focused on drug discovery, biotechnology, and therapeutics development. The Cardiovascular Center he works at is one of the top university-based cardiovascular centers globally. The specialized anesthesiologist Alddo Molinar explains that the center serves as a referral center for many cardiac care units.

Also, as Director of Clinical Research, Dr. Alddo Molinar is responsible for the planning, review, and oversight of all cardiovascular clinical research projects conducted by the center’s investigators. He is a member of numerous scientific societies and journals. His research interests include the development and evaluation of innovative therapies to treat hypertension, heart failure, renal dysfunction, and other cardiovascular diseases. His research has been funded by the National Institutes of Health, the Leona M. and Harry B. Helmsley Charitable Trust, and several pharmaceutical companies.